WEC
GOSS icon

Winslow Evans & Crocker’s Gossamer Bio GOSS Stock Holding History

Winslow Evans & Crocker’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$2K Buy
+200
New +$1.97K ﹤0.01% 1221

Other funds holding GOSS

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Winslow Evans & Crocker's GOSS Position: Q4 2020 in Review

Winslow Evans & Crocker opened a new position in Gossamer Bio (GOSS) in Q4 2020: 200 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #1221 among its holdings.

122 funds tracked by Wall St. Rank hold GOSS as of Q4 2020.

  • Winslow Evans & Crocker held 200 shares of Gossamer Bio worth $2K as of Q4 2020.
  • Gossamer Bio was a new Winslow Evans & Crocker position in Q4 2020.
  • Gossamer Bio made up ﹤0.01% of Winslow Evans & Crocker's portfolio in Q4 2020, its #1221 holding.
  • 122 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.